Completed NA INTERVENTIONAL 4-arm NCT04147845

Transepidermal Delivery of Triamcinolone Acetonide or Platelet Rich Plasma Using Either Fractional Carbon Dioxide Laser or Microneedling in Treatment of Alopecia Areata

Sponsor: Alexandria University

Interventions Fractional Carbon Dioxide Laser Microneedling using dermapen Platelet-rich plasma Triamcinolone Acetonide

Updated 5 times since 2019 Last updated: Dec 6, 2020 Started: Oct 30, 2019 Primary completion: Nov 27, 2020 Completion: Nov 27, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Alopecia Areata and is currently completed. Alexandria University leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2020 — Jan 2021 [monthly]

Recruiting NA
Dec 2019 — Feb 2020 [monthly]

Recruiting NA

First recorded

Oct 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alexandria University

Data source: Alexandria University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alexandria, Egypt